Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

ClinicalTrials.gov ID: NCT03168321

Public ClinicalTrials.gov record NCT03168321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.

Study identification

NCT ID
NCT03168321
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
813 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2017 (Actual)
Primary completion
Jun 7, 2018 (Actual)
Completion
Jun 7, 2018 (Actual)
Last update posted
Apr 1, 2021

2017 – 2018

United States locations

U.S. sites
42
U.S. states
23
U.S. cities
40
Facility City State ZIP Site status
Valeant Site 19 Phoenix Arizona 85032 —
Valeant Site 21 Phoenix Arizona 85032 —
Valeant Site 24 Hot Springs Arkansas 71913 —
Valeant Site 04 La Mesa California 91942 —
Valeant Site 02 Manhattan Beach California 90266 —
Valeant Site 42 Murrieta California 92562 —
Valeant Site 39 Sacramento California 95819 —
Valeant Site 01 San Diego California 22434 —
Valeant Site 37 Wheat Ridge Colorado 80033 —
Valeant Site 35 Boca Raton Florida 33486 —
Valeant Site 40 North Miami Beach Florida 33162 —
Valeant Site 33 Ormond Beach Florida 32174 —
Valeant Site 27 Pembroke Pines Florida 33028 —
Valeant Site 13 Sanford Florida 32771 —
Valeant Site 03 West Palm Beach Florida 33401 —
Valeant Site 26 Newnan Georgia 30263 —
Valeant Site 30 Boise Idaho 83704 —
Valeant Site 06 Arlington Heights Illinois 60005 —
Valeant Site 23 New Albany Indiana 47150 —
Valeant Site 17 South Bend Indiana 46617 —
Valeant Site 31 Overland Park Kansas 66215 —
Valeant Site 22 Louisville Kentucky 40217 —
Valeant Site 08 Metairie Louisiana 70006 —
Valeant Site 38 Detroit Michigan 48202 —
Valeant Site 16 Warren Michigan 48088 —
Valeant site 20 New York New York 10022 —
Valeant Site 36 New York New York 10075 —
Valeant Site 09 High Point North Carolina 27262 —
Valeant Site 32 Cincinnati Ohio 45236 —
Valeant Site 11 Dublin Ohio 43016 —
valeant Site 07 Gresham Oregon 97030 —
Valeant Site 15 Johnston Rhode Island 02919 —
Valeant Site 34 Knoxville Tennessee 37917 —
valeant Site 14 Nashville Tennessee 37215 —
Valeant Site 12 Austin Texas 78759 —
Valeant Site 05 Katy Texas 77494 —
Valeant Site 18 Plano Texas 75093 —
Valeant Site 25 San Antonio Texas 78213 —
Valeant Site 43 Webster Texas 77598 —
Valeant Site 41 Salt Lake City Utah 84114 —
Valeant Site 45 Norfolk Virginia 23507 —
Valeant Site 44 Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03168321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2021 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03168321 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →